Solana Co (HSDT): debt financing — Helius Medical raises $1.3M via 20% OID notes and 1.32M shares in private placement

Solana Co

Aggregate principal of $1.56M in 20% original issue discount promissory notes; gross proceeds $1.3M before fees.
Issuance of 1,320,150 common shares; notes mature July 24, 2025 or upon next registered offering.
Interest at 20% per annum upon default; net proceeds for working capital and general corporate purposes.
Directors and officers entered lock-up agreements restricting share transfers until maturity.
Placement agent Maxim Group LLC receives 7% of gross proceeds and up to $15,000 legal fee reimbursement.

item 1.01 item 2.03 item 3.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Debt Financings SEC 8-K Item 2.03/2.04 confidence 0.9

Solana Co incurred loan of $1,560,000 at 20.0% per annum maturing July 24, 2025.

Instrument: loan
Principal: $1,560,000
Rate: 20.0% per annum
Maturity: July 24, 2025
Event: incurrence

Exact text from the filing

On April 24, 2025, Helius Medical Technologies, Inc., a Delaware corporation (the “Company”) entered into a securities purchase agreement (the “Purchase Agreement”) with certain investors (the “Purchasers”) pursuant to which the Company sold, in a private placement (the “Offering”), unsecured 20% original issue discount promissory notes with an aggregate principal amount of $1,560,000 (the “Notes”).

View on SEC.gov

10 debt financings filed in the last 30 days. Browse all debt financings →

Solana Co filing history →

Source: SEC EDGAR

accession 0001558370-25-005510

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.